In a decisive market move today, Vodafone Idea shares rallied sharply, surging over 13% to ₹11.36 on the BSE, marking one of the most significant upticks in recent trading. This jump followed the telecom firm’s unveiling of a comprehensive turnaround plan centered around strengthening infrastructure, tapping new revenue sources, and addressing long-standing financial hurdles that…
Visa stock slips as earnings beat but processed transactions miss. We review results, valuation, and setup for V stock, plus the key catalysts to watch next.
SOXS stock pre-market: $1.76, heavy volume and weak technicals; Meyka AI forecast projects quarterly $3.71 upside
The Multi Commodity Exchange of India (MCX) has made a big change for gold derivatives traders. Starting January 30, 2026, MCX will widen the strike price intervals for Gold and Gold Mini options from ₹100 to ₹500. This shift comes as bullion markets stay strong and more traders use these contracts to hedge or speculate….
Earnings spotlight: WDP.BR stock at €23.30 ahead of 30 Jan 2026 results; Meyka AI forecast and valuation analysis
Intraday update: ZUGER.SW stock at CHF 9,360 as Zuger Kantonalbank readies earnings 2 Feb; Meyka forecast and analyst view
Gold price rockets to $5,500 as volatility explodes. What this means for Swiss investors, silver near $120, and how to trade extreme swings in CHF terms today.
Waiting for an IRS Refund can feel stressful, especially when money plans depend on it. Every tax season, millions of taxpayers check the IRS Refund Tracker daily, sometimes even hourly, hoping for an update. The good news is that the IRS clearly explains how the Where’s My Refund tool works, when it updates, and what…
5595.T stock closed JPY 1,736 on 30 Jan 2026 on heavy volume; we assess drivers, valuation and Meyka AI forecast
We are witnessing a defining moment in the global pharmaceutical and stock market landscape. A major agreement has been announced where AstraZeneca will pay up to $18.5 billion to CSPC Pharmaceutical Group to gain access to a new pipeline of obesity drugs. This deal stands among the largest collaborations ever seen in the obesity treatment…